Congressional trading records show Rep. Ro Khanna net selling Albertsons Companies ahead of its Q2 FY2027 earnings on October 13. Of eight disclosed trades in ACI, seven were sells against one buy. Analysts expect EPS near $0.33, down roughly 25 percent from the year-ago quarter, with revenue projected flat at approximately $18.87 billion following a prior-quarter miss that saw the company deliver $0.42 against a $0.54 consensus.
The same filings reveal a different stance on other consumer cyclical names. Khanna recorded four buys in CHWY with no sells, three buys in CMG alongside Rep. Tony Wied, and three buys in healthcare name COO. Additional activity appears in TJX, CCL and HD, where four lawmakers including Kevin Hern and Lloyd Doggett split four buys against three sells. HD itself carries a November 17 report date with consensus EPS of $3.85, a modest 3 percent increase, and revenue near $42.8 billion.
META also drew five trades split three buys to two sells from Khanna and Rep. Maria Elvira Salazar. The pattern points to selective positioning rather than blanket sector exposure. Consumer defensive faces margin pressure and softer same-store trends while certain discretionary and healthcare names appear to attract congressional capital before their own releases. EMR and TJX round out the list with balanced buy-sell counts from the same two members.
The disclosures arrive against a backdrop of elevated filing volume from several offices. Khanna's activity spans multiple consumer sub-sectors in this window, with the ACI sales standing out for both size and direction relative to the coming print. Whether these moves reflect broader economic reads on grocery inflation or category-specific views remains unclear from the filings alone.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.